PR91213

DURHAM, N.C., Aug. 18, 2021 /PRNewswire=KYODO JBN/ --

-- Highly complementary transaction strengthens BioAgilytix's ability to

support bioanalytical services across all major therapeutics in development;

adds LC/MS/MS capabilities; and expands team of seasoned scientists

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research

laboratory focused on supporting its pharmaceutical and biotech partners in all

stages of large molecule drug development, announced today that it signed a

definitive agreement to acquire MicroConstants, adding it to its family of

companies.

Logo - https://mma.prnewswire.com/media/1278852/BioAgilytix_Logo.jpg

Logo - https://mma.prnewswire.com/media/1596912/MicroConstants_Logo.jpg

MicroConstants, to be known as BioAgilytix San Diego, provides industry-leading

services in method development, validation, and sample analysis for small and

large molecule therapeutics and biomarkers using LC/MS/MS, HPLC, immunoassay

(including multiplexing and high sensitivity SIMOA) and qPCR techniques. Since

1998, MicroConstants has supported 290+ biotechnology and pharmaceutical

companies.

"We are excited to welcome the MicroConstants team to BioAgilytix and to work

with them to integrate the business," said Jim Datin, President and CEO of

BioAgilytix. "We believe that by joining forces, BioAgilytix and MicroConstants

will not only create significant scientific and performance synergies, but also

we are better able to serve the growing biotechnology community on the West

Coast. Most importantly, our customers and their patients will benefit from the

leading-edge science the combined company will bring to market."

MicroConstants, which serves clients across the pharmaceutical and biotech

industry, has deep expertise in bioanalytical testing services with over 20+

years of experience performing GLP compliant bioanalytical services. The

business will complement BioAgilytix's already impressive contract research

services for the pharmaceutical and biotech industry. MicroConstants China

remains a separate business entity and is not part of this transaction.

About BioAgilytix

BioAgilytix is a leading bioanalytical testing laboratory specializing in large

molecule bioanalysis. With laboratory locations in North Carolina's Research

Triangle area, the Cambridge area of Massachusetts, and Hamburg, Germany,

BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay

services supporting the development and release testing of biologics across a

number of industries and disease states.

BioAgilytix offers assay development, validation, and sample analysis under

non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product

release testing, stability testing, etc.). BioAgilytix also offers diagnostic

testing services at its CLIA-certified, CAP-accredited Boston laboratory.

BioAgilytix's team of highly experienced scientific and QA professionals

ensures high-quality science, data integrity and regulatory compliance through

all phases of clinical development. BioAgilytix is a trusted partner to many

top global pharmaceutical and biotech companies. For more information, visit

www.bioagilytix.com.

About MicroConstants, Inc.

MicroConstants Inc., is one of the largest bioanalytical LC/MS/MS service

providers in the United States, with headquarters in San Diego, California for

over 20 years.  MicroConstants helps its clients develop novel therapeutics by

supporting clinical and preclinical regulated bioanalysis studies. Since 1998,

MicroConstants has supported 290+ clients in 45 countries, completed over 8,200

projects, and developed more than 2,400 methods. For more information on how

MicroConstants fulfills its purpose, please visit www.microconstants.com.

Media Contact:

Pam O'Connor

BioAgilytix

+1 (919) 621-1230

pam.oconnor@bioagilytix.com

SOURCE: BioAgilytix